Kiromic Biopharma Inc (KRBP) — Working Capital to Net Assets Ratio
Kiromic Biopharma Inc (KRBP) has a Working Capital to Net Assets ratio of 139.9% as of December 2024. Working capital of $-17.60 Million (current assets of $3.30 Million minus current liabilities of $20.90 Million) is measured against net assets of $-12.59 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See KRBP free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Kiromic Biopharma Inc Working Capital to Net Assets (2018–2024)
This chart shows how Kiromic Biopharma Inc's Working Capital to Net Assets ratio has evolved across 7 annual periods from 2018 to 2024. As of December 2024, the ratio stands at 139.9%, reflecting working capital of $-17.60 Million against net assets of $-12.59 Million USD. See Kiromic Biopharma Inc (KRBP) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Kiromic Biopharma Inc (2018–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Kiromic Biopharma Inc from 2018 to 2024, covering 7 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Kiromic Biopharma Inc stock valuation.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 139.9% | $-17.60 Million | $-12.59 Million | $3.30 Million | $20.90 Million | ▼ -35.0 pp |
| 2023 | 174.9% | $-15.95 Million | $-9.12 Million | $4.43 Million | $20.38 Million | ▼ -25.9 pp |
| 2022 | 200.8% | $-11.59 Million | $-5.77 Million | $1.69 Million | $13.28 Million | ▲ +114.2 pp |
| 2021 | 86.6% | $23.66 Million | $27.32 Million | $27.07 Million | $3.41 Million | ▲ +5.0 pp |
| 2020 | 81.6% | $9.27 Million | $11.36 Million | $10.74 Million | $1.47 Million | ▲ +12.5 pp |
| 2019 | 69.1% | $1.37 Million | $1.98 Million | $2.04 Million | $673.70K | ▲ +88.1 pp |
| 2018 | -19.0% | $-50.50K | $265.30K | $560.20K | $610.70K | — |